These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 21274961)
1. Substrate selection in hearts subjected to ischemia/reperfusion: role of cardioplegic solutions and gender. Alves MG; Oliveira PJ; Carvalho RA NMR Biomed; 2011 Nov; 24(9):1029-37. PubMed ID: 21274961 [TBL] [Abstract][Full Text] [Related]
2. Gender-dependent metabolic remodeling during heart preservation in cardioplegic celsior and histidine buffer solution. Alves MG; Oliveira PF; Martins FO; Oliveira PJ; Carvalho RA J Cardiovasc Pharmacol; 2012 Aug; 60(2):227-33. PubMed ID: 22892386 [TBL] [Abstract][Full Text] [Related]
3. Gender-dependent metabolic remodeling during heart preservation in cardioplegic celsior and histidine buffer solution. Alves MG; Oliveira PF; Martins FO; Oliveira PJ; Carvalho RA J Cardiovasc Pharmacol; 2012 Feb; 59(2):151-7. PubMed ID: 21983744 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial preservation in Celsior versus histidine buffer solution during cardiac ischemia and reperfusion. Alves MG; Oliveira PJ; Carvalho RA Cardiovasc Toxicol; 2009 Dec; 9(4):185-93. PubMed ID: 19757201 [TBL] [Abstract][Full Text] [Related]
5. Anti-apoptotic protection afforded by cardioplegic celsior and histidine buffer solutions to hearts subjected to ischemia and ischemia/reperfusion. Alves MG; Machado NG; Sardão VA; Carvalho RA; Oliveira PJ J Cell Biochem; 2011 Dec; 112(12):3872-81. PubMed ID: 21866562 [TBL] [Abstract][Full Text] [Related]
6. Celsior versus custodiol: early postischemic recovery after cardioplegia and ischemia at 5 degrees C. Ackemann J; Gross W; Mory M; Schaefer M; Gebhard MM Ann Thorac Surg; 2002 Aug; 74(2):522-9. PubMed ID: 12173839 [TBL] [Abstract][Full Text] [Related]
7. Enhanced preservation of the rat heart after prolonged hypothermic ischemia with erythropoietin-supplemented Celsior solution. Watson AJ; Gao L; Sun L; Tsun J; Jabbour A; Ru Qiu M; Jansz PC; Hicks M; Macdonald PS J Heart Lung Transplant; 2013 Jun; 32(6):633-40. PubMed ID: 23701853 [TBL] [Abstract][Full Text] [Related]
8. Comparative experimental study of myocardial protection with crystalloid solutions for heart transplantation. Lima ML; Fiorelli AI; Vassallo DV; Pinheiro BB; Stolf NA; Gomes OM Rev Bras Cir Cardiovasc; 2012; 27(1):110-6. PubMed ID: 22729308 [TBL] [Abstract][Full Text] [Related]
9. Eight hours of cold static storage with adenosine and lidocaine (Adenocaine) heart preservation solutions: toward therapeutic suspended animation. Rudd DM; Dobson GP J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1552-61. PubMed ID: 21742347 [TBL] [Abstract][Full Text] [Related]
10. Direct assessment of the antioxidant effects of a new heart preservation solution, Celsior. A hemodynamic and electron spin resonance study. Pietri S; Culcasi M; Albat B; Albérici G; Menasché P Transplantation; 1994 Sep; 58(6):739-42. PubMed ID: 7940702 [No Abstract] [Full Text] [Related]
11. Importance of organ preservation solution composition in reducing myocardial edema during machine perfusion for heart transplantation. Cobert ML; Peltz M; West LM; Jessen ME Transplant Proc; 2010 Jun; 42(5):1591-4. PubMed ID: 20620480 [TBL] [Abstract][Full Text] [Related]
13. Captopril-induced glutamate release at the start of reperfusion after cold cardioplegic storage of pig hearts. Randsbaek F; Kimose HH; Bjerre T; Moldrup U; Botker HE; Nielsen TT J Thorac Cardiovasc Surg; 2000 May; 119(5):1030-8. PubMed ID: 10788826 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporine A as a Cardioprotective Agent During Donor Heart Retrieval, Storage, or Transportation: Benefits and Limitations. Gao L; Hicks M; Villanueva JE; Doyle A; Chew HC; Qui MR; Jabbour A; Dhital KK; Macdonald PS Transplantation; 2019 Jun; 103(6):1140-1151. PubMed ID: 30801551 [TBL] [Abstract][Full Text] [Related]
15. Sub-normothermic preservation of donor hearts for transplantation using a novel solution, Somah: a comparative pre-clinical study. Lowalekar SK; Cao H; Lu XG; Treanor PR; Thatte HS J Heart Lung Transplant; 2014 Sep; 33(9):963-70. PubMed ID: 25001113 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of cardiac preservation with Celsior or University of Wisconsin solution with or without prior administration of cardioplegia. Boku N; Tanoue Y; Kajihara N; Eto M; Masuda M; Morita S J Heart Lung Transplant; 2006 Feb; 25(2):219-25. PubMed ID: 16446224 [TBL] [Abstract][Full Text] [Related]
17. Early reperfusion with warm, polarizing adenosine-lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage. Rudd DM; Dobson GP J Thorac Cardiovasc Surg; 2011 Apr; 141(4):1044-55. PubMed ID: 20605028 [TBL] [Abstract][Full Text] [Related]
18. HEMO Teh ES; Zal F; Polard V; Menasché P; Chambers DJ Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):717-722. PubMed ID: 28079401 [TBL] [Abstract][Full Text] [Related]
19. Comparative effects of Celsior and a new cardioplegic solution on function, energy metabolism, and intracellular pH during long-term heart preservation. Desrois M; Caus T; Lan C; Sciaky M; Cozzone PJ; Bernard M Transplant Proc; 2002 Jun; 34(4):1259-61. PubMed ID: 12072333 [No Abstract] [Full Text] [Related]
20. Deleterious effect of hypothermia in myocardial protection against cold ischemia: a comparative study in isolated rat hearts. Lima ML; Fiorelli AI; Vassallo DV; Batista PR; Simoes FV; Fiorim J; Stefanon I; Pinheiro BB; Stolf NA; Gomes OM Transplant Proc; 2012 Oct; 44(8):2326-32. PubMed ID: 23026585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]